Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

Public health experts are concerned about mutated versions of SARS-CoV-2, the virus that causes COVID, that combine the worst elements of different strains. When two or more slightly different ...

In this episode, we discuss recombinant antibodies: what are they and what are they used for? BioTechniques Senior Editor Tristan Free, speaks to Amy Sheng (left), Technical Account Manager at Sino ...

The primary aim of any vaccine is to stimulate immune functions and confer long-lasting protection. A paper recently uploaded to the preprint server bioRxiv* by Tong et al. (17 th Feb 2021) describes ...

insights from industryDr. Tillman ZiegertManaging DirectorBiorbyt Ltd. In this interview, News-Medical speaks to Dr. Tillmann Ziegert, Managing Director at Biorbyt Ltd., about the balance between ...

Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...

The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that push up the overall cost to manufacture these drugs. These same ...

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...